-
52% off
Western Europe Telecom Operators Country Intelligence Report Bundle
Western Europe Telecom Operators Country Intelligence Report Bundle The future of Europe’s telecom industry depends on dynamic changes to business and operating models. The market is going through significant changes and the next step is to take the strategic initiative to ensure that the operators act as players in the future of the industry and not just mere observers. As a part of this bundle, you will gain access to in-depth insights available in the following reports: Austria Telecom Operators...
-
Analyst Opinions
Commerce Tomorrow – How Embedded Finance is Disrupting the Modern Economy
Embedded finance is the streamlined integration of financial services into a conventional non-financial service. It is intended to simplify financial processes for consumers and provide a better user experience by allowing them to access what they need when they need it. The key enablers for embedded finance are open banking and payment application programming interfaces (APIs). While these have advanced and matured sufficiently to enable embedded finance to become viable, it is not the case in all markets indicating that...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GS-030
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GS-030 Drug Details GS-030 is under development for the treatment of retinitis pigmentosa, geographic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – B-244
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry B-244 Drug Details B-244 is under development for the treatment of acne vulgaris, hypertension,...
-
Product Insights
Oxysterols Receptor LXR Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or Ubiquitously Expressed Nuclear Receptor or LXRB or NR1H2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players
Oxysterols Receptor LXR Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or Ubiquitously Expressed Nuclear Receptor or LXRB or NR1H2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players report provides in depth analysis on Oxysterols Receptor LXR Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or Ubiquitously Expressed Nuclear Receptor or LXRB...
-
Sector Analysis
Disposable Endoscopes Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2030
The disposable endoscopes market size was valued at $943.2 million in 2021. Disposable endoscopes are used in a variety of diagnostic and therapeutic procedures, depending upon the specific type of endoscope under review. Diseases that may occur ubiquitously, such as cancer, can be detected by almost any type of disposable endoscopes, while site-specific diseases or conditions would only be detected by a specific type. Disposable endoscopes market overview, 2015 - 2030 For more insights into the disposable endoscopes market forecast,...
-
Case Studies
Nissin Cup Noodle – COVID-19 Success Case Study
The COVID-19 pandemic has inspired shifts in consumer behavior towards meal choice and preparation. While some consumers have embraced the creativity and variety of home cooking, for others the desire for quick, easy solutions to mealtime hunger has found them seeking "emergency foods" - meal options that take minimal effort to prepare and are suited to individual consumption. This has particularly been the case in Japan, benefiting the well-known originator of instant noodles, Nissin Foods. The COVID-19 pandemic has fueled...
-
Thematic Analysis
MedTech – Thematic Research
For hundreds of years, the key drivers of progress in healthcare were biology and chemistry. Now, they are data science and software. Organizations are utilizing Internet of Things (IoT) technologies to access real-time data and gain visibility into their operations throughout the manufacturing value chain. The global IoT devices market in the healthcare sector is expected to grow at a Compound Annual Growth Rate (CAGR) of 47.3% from 2016 to 2020, to over $500M. Big Healthcare is being gradually undermined...
-
Sector Analysis
Cytomegalovirus (CMV): Opportunity Analysis and Forecasts to 2027
Cytomegalovirus (CMV) is a β human herpesvirus (HHV-5) of the herpesviridae family. Exposure to the virus can result in lytic infection, producing symptoms that range from those of a common cold to more serious morbidities, including hepatitis and pneumonitis. CMV also has the capacity to establish life-long latent infections, incorporating genomic DNA into host cells without detectable viral gene expression. CMV is a globally ubiquitous pathogen that affects 1/3 of children by the age of 5 and over half of...
-
Thematic Analysis
MedTech – Global Thematic Research
The global healthcare industry is worth $8 trillion. At $9,000 per capita, US healthcare spending is 50% higher than the world’s second highest spender – Australia – and 20 times higher than per capita levels in China Medicine is changing. For hundreds of years, the key drivers of progress were biology and chemistry. Now they are data science and software. Big Medicine and Big Pharma are being gradually undermined by swelling networks of connected biosensors, ubiquitous mobile devices and cloud-based...